Bone Care International: to Present at Smith Barney Citigroup 2005 Healthcare Conference


Middleton, Wisconsin – March 18, 2005 – Bone Care International, Inc. (Nasdaq: BCII) today announced that Paul L. Berns, President and Chief Executive Officer and Brian J. Hayden, Vice President-Finance and CFO, will be presenting at 4:15 pm EST on Wednesday, March 30, 2005 at the Smith Barney Citigroup 2005 Healthcare Conference at the Mayflower Hotel in Washington, DC. The presentation will be webcast live and available for replay for 30 days. The direct link to the webcast is:

Bone Care International ( is a specialty pharmaceutical company engaged in the discovery, development and commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Our current commercial and therapeutic focus is in nephrology, utilizing Hectorol® (doxercalciferol), our novel vitamin D hormone therapy, to treat secondary hyperparathyroidism in patients with moderate to severe chronic kidney disease and end-stage renal disease. In addition to chronic kidney disease, the Company is developing vitamin D hormone therapies to treat hyperproliferative disorders such as cancer and psoriasis.


Bone Care International, Inc.
Brian J. Hayden, Chief Financial Officer
(608) 662-7800